STAT

Opinion: New diagnostic tools are essential in the battle against antibiotic resistance

Staphylococcus aureus

A century ago, a severe bacterial infection was often a death sentence. With the advent of penicillin and the antibiotics that followed, such infections became eminently manageable, even routine. Today, though, with the rise of antimicrobial resistance, we are perilously close to returning to where we were 100 years ago.

I have a unique and uncomfortable perspective on the looming crisis of antimicrobial resistance. I am the chief technology officer SeLux Diagnostics, a startup focused on the rapid diagnosis of infectious diseases. And

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Drug Shortages, Medicare Spending On An Alzheimer’s Drug, And More
Medicare estimates a new Alzheimer’s drug could cost the program billions of dollars by next year — well beyond what Wall Street or the drug’s manufacturer project.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks